$LUVU
Luvu Brands, Inc. Stock $luvu

$luvu Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000165495421012139 Filed on November 15, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$7.186M	$6.224M	$5.367M
YoY Change	25.76%	15.97%	31.09%
Cost Of Revenue	$5.609M	$1.000K	$0.00
YoY Change	35.22%		-100.0%
Gross Profit	$1.577M	$1.499M	$1.488M
YoY Change	0.7%	0.74%	30.87%
Gross Profit Margin	21.95%	24.08%	27.72%
Selling, General & Admin	$1.248M	$1.105M	$1.000M
YoY Change	17.96%	10.5%	1.63%
% of Gross Profit	79.14%	73.72%	67.2%
Research & Development	$32.48M	$28.32M	$29.23M
YoY Change	19.01%	-3.09%
% of Gross Profit	2059.73%	1889.46%	1964.05%
Depreciation & Amortization	$77.83K	$70.69K	$52.45K
YoY Change	52.53%	34.77%	31.13%
% of Gross Profit	4.94%	4.72%	3.53%
Operating Expenses	$1.326M	$1.176M	$1.052M
YoY Change	19.57%	11.79%	2.73%
Operating Profit	$251.0K	$323.0K	$436.0K
YoY Change	-45.08%	-25.92%	285.84%
Interest Expense	-$84.00K	-$96.00K	-$107.0K
YoY Change	-4.55%	-10.28%	-32.28%
% of Operating Profit	-33.47%	-29.72%	-24.54%
Other Income/Expense, Net	-$84.00K	-$96.00K	-$107.0K
YoY Change	-108.33%	-10.28%
Pretax Income	$167.0K	$227.0K	$329.0K
YoY Change	-88.6%	-31.0%	-831.11%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%	0.0%	0.0%
Net Earnings	$167.0K	$227.0K	$329.0K
YoY Change	-88.6%	-31.0%	-831.11%
Net Earnings / Revenue	2.32%	3.65%	6.13%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	75.14M shares	75.04M shares	73.45M shares
Diluted Shares Outstanding	76.61M shares	76.58M shares	76.03M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.081M	$961.0K	$932.0K
YoY Change	6.5%	3.11%	61.81%
Cash & Equivalents	$1.081M	$961.0K	$932.0K
Short-Term Investments
Other Short-Term Assets	$168.0K	$159.0K	$90.00K
YoY Change	93.1%	76.67%	100.0%
Inventory	$3.456M	$3.503M	$2.186M
Prepaid Expenses	$168.0K	$159.0K
Receivables	$920.0K	$1.087M	$1.039M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.625M	$5.710M	$4.247M
YoY Change	24.81%	34.45%	27.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.863M	$1.915M	$1.033M
YoY Change	-53.34%	85.38%	-9.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$100.0K	$95.00K	$17.00K
YoY Change	316.67%	458.82%	54.55%
Total Long-Term Assets	$4.395M	$4.517M	$1.050M
YoY Change	9.41%	330.19%	-8.46%
TOTAL ASSETS
Total Short-Term Assets	$5.625M	$5.710M	$4.247M
Total Long-Term Assets	$4.395M	$4.517M	$1.050M
Total Assets	$10.02M	$10.23M	$5.297M
YoY Change	17.55%	93.07%	18.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.597M	$2.725M	$2.422M
YoY Change	2.89%	12.51%	-9.25%
Accrued Expenses	$528.0K	$584.0K	$640.0K
YoY Change	-26.36%	-8.75%	-24.35%
Deferred Revenue
YoY Change
Short-Term Debt	$1.065M	$1.114M	$0.00
YoY Change
Long-Term Debt Due	$296.0K	$312.0K	$2.480M
YoY Change	-84.04%	-87.42%	1.56%
Total Short-Term Liabilities	$4.776M	$5.005M	$5.542M
YoY Change	-6.28%	-9.69%	-6.97%
LONG-TERM LIABILITIES
Long-Term Debt	$1.258M	$1.327M	$694.0K
YoY Change	183.33%	91.21%	12.66%
Other Long-Term Liabilities	$2.256M	$2.341M
YoY Change	-7.43%
Total Long-Term Liabilities	$3.514M	$3.668M	$694.0K
YoY Change	21.97%	428.53%	-3.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.776M	$5.005M	$5.542M
Total Long-Term Liabilities	$3.514M	$3.668M	$694.0K
Total Liabilities	$8.290M	$8.673M	$6.236M
YoY Change	3.92%	39.08%	-6.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.199M	-$5.366M
YoY Change
Common Stock	$752.0K	$750.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.730M	$1.554M	-$939.0K
YoY Change
Total Liabilities & Shareholders Equity	$10.02M	$10.23M	$5.297M
YoY Change	17.55%	93.07%	18.24%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	$167.0K	$227.0K	$329.0K
YoY Change	-88.6%	-31.0%	-831.11%
Depreciation, Depletion And Amortization	$77.83K	$70.69K	$52.45K
YoY Change	52.53%	34.77%	31.13%
Cash From Operating Activities	$275.0K	$169.0K	$130.0K
YoY Change	3.38%	30.0%	-236.84%
INVESTING ACTIVITIES
Capital Expenditures	$4.000K	$61.00K	$28.00K
YoY Change	-107.41%	117.86%	-450.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$4.000K	-$50.00K	-$27.00K
YoY Change	-107.41%	85.19%	237.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$200.0K	$154.0K
YoY Change		29.87%
Cash From Financing Activities	-159.0K	-$135.0K	-$323.0K
YoY Change	23.26%	-58.2%	-1176.67%
NET CHANGE
Cash From Operating Activities	275.0K	$169.0K	$130.0K
Cash From Investing Activities	4.000K	-$50.00K	-$27.00K
Cash From Financing Activities	-159.0K	-$135.0K	-$323.0K
Net Change In Cash	120.0K	-$16.00K	-$220.0K
YoY Change	44.58%	-92.73%	201.37%
FREE CASH FLOW
Cash From Operating Activities	$275.0K	$169.0K	$130.0K
Capital Expenditures	$4.000K	$61.00K	$28.00K
Free Cash Flow	$271.0K	$108.0K	$102.0K
YoY Change	-15.31%	5.88%	-217.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	961000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	977000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1087000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1134000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	3503000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	5647000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1915000	USD
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	75137890	shares
CY2021Q2	us-gaap	Inventory Net InventoryNet	3391000	USD
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	159000	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	145000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	5710000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1934000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	250000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5005000	USD
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	25000	USD
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	27000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5212000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2482000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2554000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1176000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1327000	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	130000	USD
CY2021Q3	us-gaap	Other Assets OtherAssets	95000	USD
CY2021Q2	us-gaap	Other Assets OtherAssets	84000	USD
CY2021Q3	us-gaap	Assets Assets	10227000	USD
CY2021Q2	us-gaap	Assets Assets	10246000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2725000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2669000	USD
CY2021Q3	us-gaap	Debt Current DebtCurrent	1426000	USD
CY2021Q2	us-gaap	Debt Current DebtCurrent	1599000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	694000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	270000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1288000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2341000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2423000	USD
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3668000	USD
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3711000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	8673000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	8923000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5700000	shares
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75037890	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	750000	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	750000	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6170000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6166000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5366000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5593000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1554000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1323000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10227000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10246000	USD
CY2021Q3	us-gaap	Revenues Revenues	6224000	USD
CY2020Q3	us-gaap	Revenues Revenues	5367000	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4725000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3879000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	1499000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	1488000	USD
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	132000	USD
CY2020Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	69000	USD
CY2021Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	261000	USD
CY2020Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	267000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	712000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	664000	USD
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	71000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	329000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	1052000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	323000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	436000	USD
CY2021Q3	us-gaap	Financing Interest Expense FinancingInterestExpense	96000	USD
CY2020Q3	us-gaap	Financing Interest Expense FinancingInterestExpense	107000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-96000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-107000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	227000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	227000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	329000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75037890	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73452596	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76584978	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76034134	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-1274000	USD
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	6000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	329000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-939000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1323000	USD
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	4000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	227000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1554000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	227000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	329000	USD
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	71000	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6000	USD
CY2021Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2020Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000	USD
CY2021Q3	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	71000	USD
CY2020Q3	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	80000	USD
CY2021Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	47000	USD
CY2020Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	97000	USD
CY2021Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-113000	USD
CY2020Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-201000	USD
CY2021Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-23000	USD
CY2020Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-35000	USD
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	58000	USD
CY2020Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-13000	USD
CY2021Q3	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-105000	USD
CY2020Q3	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-93000	USD
CY2021Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5000	USD
CY2020Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6000	USD
CY2021Q3	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-63000	USD
CY2020Q3	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-97000	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	169000	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50000	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27000	USD
CY2021Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	200000	USD
CY2020Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	154000	USD
CY2021Q3	us-gaap	Proceeds From Unsecured Lines Of Credit ProceedsFromUnsecuredLinesOfCredit	200000	USD
CY2020Q3	us-gaap	Proceeds From Unsecured Lines Of Credit ProceedsFromUnsecuredLinesOfCredit	0	USD
CY2021Q3	luvu	Net Cash Provided By Repaid To Line Of Credit NetCashProvidedByRepaidToLineOfCredit	-3000	USD
CY2021Q3	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2000	USD
CY2021Q3	luvu	Investment In Equipment And Leasehold Improvements InvestmentInEquipmentAndLeaseholdImprovements	-50000	USD
CY2020Q3	luvu	Investment In Equipment And Leasehold Improvements InvestmentInEquipmentAndLeaseholdImprovements	-27000	USD
CY2020Q3	luvu	Net Cash Provided By Repaid To Line Of Credit NetCashProvidedByRepaidToLineOfCredit	45000	USD
CY2021Q3	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	USD
CY2020Q3	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	56000	USD
CY2021Q3	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	66000	USD
CY2020Q3	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	125000	USD
CY2020Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3000	USD
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61000	USD
CY2020Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28000	USD
CY2020Q3	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2000	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-135000	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-323000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-220000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	977000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1152000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	961000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	932000	USD
CY2021Q3	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2020Q3	us-gaap	Notes Issued1 NotesIssued1	35000	USD
CY2021Q3	us-gaap	Interest Paid InterestPaid	85000	USD
CY2020Q3	us-gaap	Interest Paid InterestPaid	106000	USD
CY2021Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2021Q3	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">These consolidated financial statements include the accounts and operations of our wholly owned operating subsidiaries, OneUp and Foam Labs. Intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current year presentation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">The accompanying consolidated condensed financial statements have been prepared in accordance with GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. These consolidated condensed financial statements and notes should be read in conjunction with the Company’s consolidated financial statements contained in the Company’s 2021 10-K.</p>
CY2021Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates in these consolidated financial statements include estimates of: income taxes; tax valuation reserves; allowances for doubtful accounts; inventory valuation and reserves; share-based compensation; and useful lives for depreciation and amortization. Actual results could differ materially from these estimates. </p>
CY2021Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	16965000	USD
CY2021Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17015000	USD
CY2021Q2	luvu	Allowance For Doubtful Accounts Receivables AllowanceForDoubtfulAccountsReceivables	1000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1134000	USD
CY2021Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">The Company maintains its cash accounts with banks located in Georgia. The total cash balances are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per bank. The Company had bank balances on deposit at September 30, 2021 that exceeded the balance insured by the FDIC by $833,857. Accounts receivable are typically unsecured and are derived from revenue earned from customers primarily located in North America and Europe.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">During the three months ended September 30, 2021, we purchased 38% of total inventory purchases from one vendor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">During the fiscal year ended June 30, 2021, we purchased 34% of total inventory purchases from one vendor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">As of September 30, 2021, two of the Company’s customers represents 46% and 14% of the total accounts receivables, respectively. As of June 30, 2021, two of the Company’s customers represents 40% and 14% of the total accounts receivables, respectively. For the three months ended September 30, 2021, sales to and through Amazon accounted for 29% of our net sales, respectively.</p>
CY2021Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	833857000	USD
CY2021Q3	us-gaap	Prepaid Advertising PrepaidAdvertising	5000000	USD
CY2021Q2	us-gaap	Prepaid Advertising PrepaidAdvertising	5000000	USD
CY2021Q3	us-gaap	Advertising Expense AdvertisingExpense	131890000	USD
CY2020Q3	us-gaap	Advertising Expense AdvertisingExpense	68530000	USD
CY2021Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	28323000	USD
CY2020Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	29225000	USD
CY2021Q3	luvu	Impairment Or Disposal Of Long Lived Assetspolicy ImpairmentOrDisposalOfLongLivedAssetspolicy	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">Long-lived assets to be held are reviewed for events or changes in circumstances which indicate that their carrying value may not be recoverable. They are tested for recoverability using undiscounted cash flows to determine whether or not impairment to such value has occurred as required by Financial Accounting Standards Board (“<em>FASB”) ASC Topic No. 360, Property, Plant, and Equipment</em>. The Company has determined that there was no impairment at September 30, 2021.</p>
CY2021Q3	us-gaap	Inventory Net InventoryNet	3503000	USD
CY2020Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	88120000	USD
CY2021Q3	luvu	Rental Abatement RentalAbatement	103230000	USD
CY2021Q3	us-gaap	Capital Leases Contingent Rental Payments Due CapitalLeasesContingentRentalPaymentsDue	51615000	USD
CY2021Q3	luvu	Final Two Months Rent FinalTwoMonthsRent	61605	USD
CY2021Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	163188000	USD
CY2021Q3	us-gaap	Revenues Revenues	6224000	USD
CY2020Q3	us-gaap	Revenues Revenues	5367000	USD
CY2021Q3	luvu	Percent Change In Sales PercentChangeInSales	0.16	pure
CY2021Q3	us-gaap	Gross Profit GrossProfit	1499000	USD
CY2021Q3	luvu	Gross Profit Margin GrossProfitMargin	0.24	pure
CY2020Q3	us-gaap	Gross Profit GrossProfit	1488000	USD
CY2020Q3	luvu	Gross Profit Margin GrossProfitMargin	0.28	pure
CY2021Q3	luvu	Percent Change PercentChange	0.01	pure
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6650000	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8700000	shares
CY2021Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1768000	USD
CY2021Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1637000	USD
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	468000	USD
CY2021Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	396000	USD
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1440000	USD
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1531000	USD
CY2021Q3	us-gaap	Inventory Gross InventoryGross	3676000	USD
CY2021Q2	us-gaap	Inventory Gross InventoryGross	3564000	USD
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	173000	USD
CY2021Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	173000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	3391000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5672000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5620000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3757000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3686000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1915000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1934000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	70688	USD
CY2020Q3	us-gaap	Depreciation Depreciation	52452	USD
CY2021Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	404000	USD
CY2021Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	509000	USD
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	180000	USD
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	185000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	584000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	694000	USD
CY2021Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1080000	USD
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1083000	USD
CY2021Q3	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	0	USD
CY2021Q2	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	100000	USD
CY2021Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	218000	USD
CY2021Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	219000	USD
CY2021Q3	us-gaap	Mediumterm Notes Current MediumtermNotesCurrent	86000	USD
CY2021Q2	us-gaap	Mediumterm Notes Current MediumtermNotesCurrent	152000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	8000	USD
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	8000	USD
CY2021Q3	us-gaap	Debt Current DebtCurrent	1426000	USD
CY2021Q2	us-gaap	Debt Current DebtCurrent	1599000	USD
CY2021Q3	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	400000	USD
CY2021Q2	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	300000	USD
CY2021Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	17000	USD
CY2021Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	19000	USD
CY2021Q3	us-gaap	Other Notes Payable OtherNotesPayable	794000	USD
CY2021Q2	us-gaap	Other Notes Payable OtherNotesPayable	853000	USD
CY2021Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	116000	USD
CY2021Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	116000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1327000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1288000	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	100	USD
CY2021Q3	luvu	Share Based Compensation Arrangements By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardVestingPeriod1	4
CY2021Q3	luvu	Forfeiture Rate ForfeitureRate	0	pure
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2021Q3	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	400000	USD
CY2021Q2	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	300000	USD
CY2021Q2	us-gaap	Notes Payable NotesPayable	400000	USD
CY2021Q3	us-gaap	Notes Payable NotesPayable	400000	USD
CY2021Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	116000	USD
CY2021Q3	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	116000	USD
CY2021Q2	luvu	Notes Payable Related Parties Current NotesPayableRelatedPartiesCurrent	0	USD
CY2021Q3	luvu	Notes Payable Related Parties Current NotesPayableRelatedPartiesCurrent	0	USD
CY2021Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	116000	USD
CY2021Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	116000	USD
CY2021Q3	us-gaap	Line Of Credit Facility Collateral LineOfCreditFacilityCollateral	85% of eligible accounts receivable (as defined in the agreement) for the purpose of improving working capital.
CY2021Q3	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	2.5% over the lenders Index Rate.
CY2021Q3	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.025	pure
CY2021Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2350000	shares
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y6M
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.04
CY2021Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1687500	shares
CY2021Q3	luvu	Sharebased Compensation Not Yet Recognized SharebasedCompensationNotYetRecognized	34862	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6000	USD
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	3400000	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	4300000	shares
CY2021Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	7700000	shares
CY2021Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.08	pure
CY2021Q3	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	1096200000	USD
CY2021Q3	us-gaap	Federal Home Loan Bank Advances Interest Rate FederalHomeLoanBankAdvancesInterestRate	0.010	pure
CY2021Q3	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	61691000	USD
CY2021Q3	luvu	Weighted Average Discount Rate WeightedAverageDiscountRate	0.1449	pure
CY2021Q3	luvu	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	2482000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	270000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2341000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2611000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	614000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	642000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	680000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	721000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1290000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling After Year Five OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive	3947000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2611000	USD
CY2021Q3	luvu	Equipment Notes Payable EquipmentNotesPayable	1435356	USD
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.20	pure
CY2021Q3	luvu	Stock Options Were Exercised For Cash StockOptionsWereExercisedForCash	100000	shares
CY2021Q4	luvu	Unsecured Note Payable UnsecuredNotePayable	100000	USD
CY2021Q3	luvu	Cash Price Per Share CashPricePerShare	0.03
CY2021Q3	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	237000	USD
CY2021Q3	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	303000	USD
CY2021Q3	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	282000	USD
CY2021Q3	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	236000	USD
CY2021Q3	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	124000	USD
CY2021Q3	luvu	Future Minimum Lease Payments FutureMinimumLeasePayments	1182000	USD
CY2021Q3	us-gaap	Contractual Obligation ContractualObligation	1012000	USD
CY2021Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	218000	USD
CY2021Q3	us-gaap	Other Notes Payable OtherNotesPayable	794000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	3400000	shares
CY2021Q3	luvu	Number Of Shares Available For Issuance Under Plan NumberOfSharesAvailableForIssuanceUnderPlan	1050000	shares
CY2021Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2500000	shares
CY2021Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.04
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	974300000	USD
CY2021Q3	luvu	Weighted Average Exercise Price Forfeited Or Expired WeightedAverageExercisePriceForfeitedOrExpired	0.03
CY2021Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2350000	shares
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.04
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	796800000	USD
CY2021Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1687500	shares
CY2021Q3	luvu	Weighted Average Exercise Price Outstanding Options Exercisable WeightedAverageExercisePriceOutstandingOptionsExercisable	0.03
CY2021Q3	luvu	Aggregate Intrinsic Value Exercisable AggregateIntrinsicValueExercisable	589200	USD
CY2021Q3	us-gaap	Share Price SharePrice	0.38
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	150000	shares
CY2021Q3	luvu	Common Stock Shares Issued For Non Affiliated Employee CommonStockSharesIssuedForNonAffiliatedEmployee	100000	shares

Files In Submission

Name	View Source	Status
0001654954-21-012139-index-headers.html	Edgar Link	pending
0001654954-21-012139-index.html	Edgar Link	pending
0001654954-21-012139.txt	Edgar Link	pending
0001654954-21-012139-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
luvu-20210930.xsd	Edgar Link	pending
luvu-20210930_cal.xml	Edgar Link	unprocessable
luvu-20210930_def.xml	Edgar Link	unprocessable
luvu-20210930_lab.xml	Edgar Link	unprocessable
luvu-20210930_pre.xml	Edgar Link	unprocessable
luvu_10q.htm	Edgar Link	pending
luvu_10q_htm.xml	Edgar Link	completed
luvu_ex311.htm	Edgar Link	pending
luvu_ex312.htm	Edgar Link	pending
luvu_ex321.htm	Edgar Link	pending
luvu_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUVU
Luvu Brands, Inc. Stock $luvu

2021 Q4 Form 10-Q Financial Statement

#000165495421012139 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUVU Luvu Brands, Inc. Stock $luvu

2021 Q4 Form 10-Q Financial Statement

#000165495421012139 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUVU
Luvu Brands, Inc. Stock $luvu